Mitochondrial Dynamics and UCP2 - Endothelial Dysfunction in Human Obesity
线粒体动力学和 UCP2 - 人类肥胖中的内皮功能障碍
基本信息
- 批准号:8583774
- 负责人:
- 金额:$ 55.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-01 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
Recent studies have emphasized that mitochondria in endothelial cells play an important role in signaling in response to environmental cues, including nutrient excess. Mitochondrial signaling is mediated in large part by regulated production of reactive oxygen species (ROS) by components of the electron transport chain. Physiological signaling depends on control of membrane potential by uncoupling protein-2 (UCP2) and preserved integrity of mitochondrial proteins and mtDNA via an appropriate balance between mitochondrial fission and fusion to maintain normal mitochondrial networks (mitochondrial dynamics). Obesity is associated with an imbalance between energy supply and demand in the body. We hypothesize that chronic energy excess creates a vicious cycle of increased ROS that triggers mitochondrial fragmentation and an inadequate UCP-2 response that further increases ROS and impairs endothelial function. In this project, we will relate nitric oxide signaling and endothelium-dependent vasodilation to relevant aspects of mitochondrial function in freshly isolated arterial endothelial cells from obese patients and from healthy volunteers exposed to two human models of energy excess. Our preliminary data show impaired eNOS signaling, decreased UCP2, mitochondrial fragmentation, and an increase in the fission protein Fis1 in endothelial cells collected from obese patients. Our project has 3 specific aims: For Aim 1, we will collect arterial endothelial cells from obese patients and measure mitochondrial ROS, network extent, and expression of UCP-2, Mfn2, and Fis1 and relate the findings to endothelium- dependent vasodilation in the arm and to eNOS activation in the freshly isolated cells. We will also determine whether silencing Fis1 or over-expressing UCP-2 or Mfn2 restores eNOS activation. In Aim 2, we will determine whether altered dynamics and UCP-2 contribute to endothelial dysfunction induced by Intralipid infusion (energy excess), and in Aim 3, we will determine whether these mechanisms contribute to endothelial dysfunction induced by bed rest (decreased energy demand). We anticipate increased ROS, network fragmentation, decreased UCP2, and impaired eNOS activation in cells from obese patients. If Intralipid and bed rest induce an obese endothelial phenotype and if over- expressing UCP-2 or silencing Fis1 reverses endothelial dysfunction, we will have strong evidence that these mechanisms contribute to the pathogenesis of endothelial dysfunction in human obesity.
描述(由申请人提供):
最近的研究强调,内皮细胞中的线粒体在响应环境线索(包括营养过量)的信号中起着重要作用。线粒体信号传导在很大程度上是通过电子传输链的组件对活性氧(ROS)的调节产生的。生理信号传导取决于通过解偶联蛋白2(UCP2)(UCP2)的控制以及线粒体蛋白和mTDNA的完整性,通过线粒体裂变和融合之间的适当平衡,以保持正常的线粒体网络(线粒体动力学)。肥胖与体内能量供应之间的不平衡有关。我们假设慢性能量过量产生了ROS增加的恶性循环,从而触发线粒体碎片和UCP-2不足的响应,从而进一步增加了ROS并损害内皮功能。在这个项目中,我们将将一氧化氮信号传导和内皮依赖性血管舒张与来自肥胖患者新鲜分离的动脉内皮细胞中线粒体功能的相关方面,以及来自健康的志愿者,暴露于两个人类的能量过量模型中。我们的初步数据显示,eNOS信号传导受损,UCP2降低,线粒体碎片化以及从肥胖患者收集的内皮细胞中裂变蛋白FIS1的增加。我们的项目具有3个特定目的:对于AIM 1,我们将收集来自肥胖患者的动脉内皮细胞,并测量UCP-2,MFN2和FIS1的线粒体ROS,网络范围以及表达,并将发现与内皮依赖的血管溶液相关联在臂中依赖于内新鲜分离的细胞中的eNOS和eNOS激活。我们还将确定沉默的FIS1或过表达UCP-2或MFN2是否会恢复ENOS激活。在AIM 2中,我们将确定动力学和UCP-2的改变是否有助于由脂质内输注引起的内皮功能障碍(能量过量),在AIM 3中,我们将确定这些机制是否有助于由床静电静电造成的内皮功能障碍(减少能量需求)。我们预计ROS增加,网络破碎,UCP2降低以及肥胖患者细胞中的ENOS激活受损。如果静脉内和床休息会诱导肥胖的内皮表型,如果过度表达UCP-2或沉默的FIS1逆转内皮功能障碍,我们将有强有力的证据表明,这些机制有助于人类肥胖症内皮功能障碍的发病机理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Joseph A. Vita其他文献
962-64 Determination of Extent of Viable Myocardium within Infarct-Related Arterial Perfusion Beds Using Intracoronary Tc-99m-Sestamibi Injection
- DOI:10.1016/0735-1097(95)92357-b10.1016/0735-1097(95)92357-b
- 发表时间:1995-02-011995-02-01
- 期刊:
- 影响因子:
- 作者:Jeffrey I. Leavitt;Chanh Syravanh;Joseph A. Vita;Martha Nykiel;Donald E. Tow;Thomas P RoccoJeffrey I. Leavitt;Chanh Syravanh;Joseph A. Vita;Martha Nykiel;Donald E. Tow;Thomas P Rocco
- 通讯作者:Thomas P RoccoThomas P Rocco
Usefulness and tolerability of hirulog, a direct thrombin-inhibitor, in unstable angina pectoris.
水蛭素(一种直接凝血酶抑制剂)在不稳定型心绞痛中的用途和耐受性。
- DOI:10.1016/0002-9149(93)90179-g10.1016/0002-9149(93)90179-g
- 发表时间:19931993
- 期刊:
- 影响因子:0
- 作者:Gaurav Sharma;Gaurav Sharma;Gaurav Sharma;D. Lapsley;D. Lapsley;D. Lapsley;Joseph A. Vita;Joseph A. Vita;Joseph A. Vita;Satish C. Sharma;Satish C. Sharma;Satish C. Sharma;Elizabeth Coccio;Elizabeth Coccio;Elizabeth Coccio;Burt Adelman;Burt Adelman;Burt Adelman;Joseph Loscalzo;Joseph Loscalzo;Joseph LoscalzoGaurav Sharma;Gaurav Sharma;Gaurav Sharma;D. Lapsley;D. Lapsley;D. Lapsley;Joseph A. Vita;Joseph A. Vita;Joseph A. Vita;Satish C. Sharma;Satish C. Sharma;Satish C. Sharma;Elizabeth Coccio;Elizabeth Coccio;Elizabeth Coccio;Burt Adelman;Burt Adelman;Burt Adelman;Joseph Loscalzo;Joseph Loscalzo;Joseph Loscalzo
- 通讯作者:Joseph LoscalzoJoseph Loscalzo
Early evidence of endothelial vasodilator dysfunction at coronary branch points.
冠状动脉分支点内皮血管舒张功能障碍的早期证据。
- DOI:
- 发表时间:19901990
- 期刊:
- 影响因子:37.8
- 作者:J. M. McLenachan;Joseph A. Vita;R. D. Fish;C. Treasure;David A. Cox;Peter Ganz;A. SelwynJ. M. McLenachan;Joseph A. Vita;R. D. Fish;C. Treasure;David A. Cox;Peter Ganz;A. Selwyn
- 通讯作者:A. SelwynA. Selwyn
Small vessel coronary artery disease in cardiac transplant patients
- DOI:10.1016/0735-1097(90)92222-n10.1016/0735-1097(90)92222-n
- 发表时间:1990-02-011990-02-01
- 期刊:
- 影响因子:
- 作者:Charles B. Treasure;Joseph A. Vita;Peter Ganz;Gilbert H. Mudge;R.Wayne Alexander;Andrew P. Selwyn;R.David FishCharles B. Treasure;Joseph A. Vita;Peter Ganz;Gilbert H. Mudge;R.Wayne Alexander;Andrew P. Selwyn;R.David Fish
- 通讯作者:R.David FishR.David Fish
PROTEIN KINASE-C BETA ACTIVATION CONTRIBUTES TO IMPAIRED ENDOTHELIAL INSULIN SIGNALING IN HUMANS WITH DIABETES MELLITUS
- DOI:10.1016/s0735-1097(12)62134-210.1016/s0735-1097(12)62134-2
- 发表时间:2012-03-272012-03-27
- 期刊:
- 影响因子:
- 作者:Corey E. Tabit;Sherene M. Shenouda;Monika Holbrook;Alissa A. Frame;Matthew A. Kluge;Mai-Ann Duess;Brian H. Kim;Aaron D. Levit;Aaron Held;James L. Rosenzweig;Neil B. Ruderman;Joseph A. Vita;Naomi M. HamburgCorey E. Tabit;Sherene M. Shenouda;Monika Holbrook;Alissa A. Frame;Matthew A. Kluge;Mai-Ann Duess;Brian H. Kim;Aaron D. Levit;Aaron Held;James L. Rosenzweig;Neil B. Ruderman;Joseph A. Vita;Naomi M. Hamburg
- 通讯作者:Naomi M. HamburgNaomi M. Hamburg
共 7 条
- 1
- 2
Joseph A. Vita的其他基金
MITOCHONDRIAL DYSFUNCTION IN THE DIABETIC ENDOTHELIUM
糖尿病内皮线粒体功能障碍
- 批准号:81096568109656
- 财政年份:2011
- 资助金额:$ 55.53万$ 55.53万
- 项目类别:
Boston University Medical Center Leadership Program in Vascular Medicine
波士顿大学医学中心血管医学领导力项目
- 批准号:75660107566010
- 财政年份:2007
- 资助金额:$ 55.53万$ 55.53万
- 项目类别:
Boston University Medical Center Leadership Program in Vascular Medicine
波士顿大学医学中心血管医学领导力项目
- 批准号:73518577351857
- 财政年份:2007
- 资助金额:$ 55.53万$ 55.53万
- 项目类别:
Boston University Medical Center Leadership Program in Vascular Medicine
波士顿大学医学中心血管医学领导力项目
- 批准号:77676817767681
- 财政年份:2007
- 资助金额:$ 55.53万$ 55.53万
- 项目类别:
Boston University Medical Center Leadership Program in Vascular Medicine
波士顿大学医学中心血管医学领导力项目
- 批准号:70668957066895
- 财政年份:2007
- 资助金额:$ 55.53万$ 55.53万
- 项目类别:
Determinants of Shear Stress-Mediated Arterial Remodeling
剪应力介导的动脉重塑的决定因素
- 批准号:74523587452358
- 财政年份:2006
- 资助金额:$ 55.53万$ 55.53万
- 项目类别:
Vascular Consequences of Insulin Resistance and Obesity
胰岛素抵抗和肥胖对血管的影响
- 批准号:78510797851079
- 财政年份:2006
- 资助金额:$ 55.53万$ 55.53万
- 项目类别:
Vascular Consequences of Insulin Resistance and Obesity
胰岛素抵抗和肥胖对血管的影响
- 批准号:76210457621045
- 财政年份:2006
- 资助金额:$ 55.53万$ 55.53万
- 项目类别:
Determinants of Shear Stress-Mediated Arterial Remodeling
剪应力介导的动脉重塑的决定因素
- 批准号:72782817278281
- 财政年份:2006
- 资助金额:$ 55.53万$ 55.53万
- 项目类别:
相似国自然基金
促生长激素释放激素激动剂抑制平滑肌细胞转分化对动脉粥样硬化的影响及机制研究
- 批准号:81900389
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
MEK1/2抑制剂协同肝X受体激动剂促进动脉粥样硬化斑块稳定与消退
- 批准号:81573427
- 批准年份:2015
- 资助金额:65.0 万元
- 项目类别:面上项目
LXRβ选择性激动剂抗动脉粥样硬化的药理学及其作用机制研究
- 批准号:81503065
- 批准年份:2015
- 资助金额:17.9 万元
- 项目类别:青年科学基金项目
PPAR-α激动剂影响高同型半胱氨酸血症致动脉粥样硬化的免疫学机制
- 批准号:81000115
- 批准年份:2010
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
CRP诱导RAGE表达的信号通路分析及药物干预研究
- 批准号:30971253
- 批准年份:2009
- 资助金额:8.0 万元
- 项目类别:面上项目
相似海外基金
The role of Immune-responsive gene 1 and itaconate in atherosclerotic disease
免疫反应基因1和衣康酸在动脉粥样硬化疾病中的作用
- 批准号:1060764110607641
- 财政年份:2023
- 资助金额:$ 55.53万$ 55.53万
- 项目类别:
Influence of T cell genotype/phenotype in atherosclerotic cardiovascular disease
T细胞基因型/表型对动脉粥样硬化性心血管疾病的影响
- 批准号:1075411510754115
- 财政年份:2023
- 资助金额:$ 55.53万$ 55.53万
- 项目类别:
Evaluation of anti-fibrotic and anti-inflammatory semi-synthetic oxysterol, Oxy210, as a therapeutic drug candidate for non-alcoholic steatohepatitis
抗纤维化和抗炎半合成氧甾醇 Oxy210 作为非酒精性脂肪性肝炎候选治疗药物的评价
- 批准号:1069713210697132
- 财政年份:2023
- 资助金额:$ 55.53万$ 55.53万
- 项目类别:
The role of GATA3-positive macrophages in cardiovascular pathologies
GATA3 阳性巨噬细胞在心血管病理中的作用
- 批准号:1064388810643888
- 财政年份:2022
- 资助金额:$ 55.53万$ 55.53万
- 项目类别:
Innate immune response signaling in cardiac injury healing
心脏损伤愈合中的先天免疫反应信号
- 批准号:1035002010350020
- 财政年份:2022
- 资助金额:$ 55.53万$ 55.53万
- 项目类别: